Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Xylooligosaccharides (XOS) & Pre-Diabetic Condition, the randomized clinical prevention trial NCT01944904 - Xylooligosaccharides (XOS) vs Placebo & Pre-Diabetic Condition revealed that prebiotic Xylooligosaccharides (XOS) could potentially be advantageous in reversing gut microbiota changes during diabetes development (1).
The randomized prevention trial XXX - Xylooligosaccharides (XOS) vs Placebo & Pre-Diabetic Condition revealed that further studies are needed to determine the role of Enterorhabdus, [Coriobacteriia / Coriobacteria](brain://naq1ZnKM9EWbKTheAB…